ClinConnect ClinConnect Logo
Search / Trial NCT01809665

ProMRI PROVEN Master Study

Launched by BIOTRONIK SE & CO. KG · Mar 12, 2013

Trial Information

Current as of May 30, 2025

Completed

Keywords

Icd Therapy Crt P Therapy Mri

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Written informed consent
  • Able and willing to complete MRI testing
  • Able and willing to activate and use the Cardio Messenger
  • Able and willing to complete all testing required by the clinical protocol
  • Available for all follow-up visits at the investigational site
  • Standard indication for single, dual, or triple chamber ICD or CRT-P.
  • ICD or CRT-P system to be implanted in the pectoral region
  • Patient body height ≥ 140 cm
  • Age ≥ 18 years
  • Exclusion Criteria:
  • Standard contraindication for single, dual, or triple chamber ICD or CRT-P.
  • Systems with an atrial lead: The patient has persistent (lasting longer than 7 days or requiring cardioversion) or permanent atrial arrhythmia
  • Patient has other medical implants that may interact with MRI, e.g. abandoned pacemaker/ICD leads, lead extensions, mechanical valves, other active medical devices, non-MRI compatible devices
  • Patient has other metallic artifacts / components in body that may interact with MRI
  • Life expectancy of less than eight months
  • Cardiac surgery in the next eight months
  • Pregnant or breastfeeding
  • Enrolled in another non-observational cardiac clinical investigation

About Biotronik Se & Co. Kg

Biotronik SE & Co. KG is a global leader in the development of innovative medical technology, specializing in cardiovascular and endovascular solutions. With a strong commitment to enhancing patient outcomes, the company focuses on advanced therapies and devices, including implantable cardioverter-defibrillators, cardiac resynchronization therapy, and vascular interventions. Biotronik's rigorous research and development initiatives, coupled with its dedication to clinical excellence, position the company at the forefront of medical advancement, striving to improve quality of life for patients worldwide. Through strategic partnerships and a robust clinical trial portfolio, Biotronik continues to drive innovation and set new standards in healthcare.

Locations

Adelaide, , Australia

Montreal, Quebec, Canada

Toronto, Ontario, Canada

Perth, , Australia

Box Hill, Victoria, Australia

Toronto, Ontario, Canada

Camperdown, New South Wales, Australia

Bedford Park, South Australia, Australia

Adelaide, , Australia

Würzburg, , Germany

Essen, , Germany

St. Poelten, , Austria

Brest, , France

Bonn, , Germany

Budapest, , Hungary

Coburg, , Germany

Olomouc, , Czech Republic

Linz, , Austria

Zürich, , Switzerland

Edmonton, , Canada

Perth, , Australia

Sydney, , Australia

Sherbrooke, Quebec, Canada

Tours, , France

Villingen Schwenningen, , Germany

Patients applied

0 patients applied

Trial Officials

Wolfgang R. Bauer, Prof.Dr.Dr.

Principal Investigator

Universitätsklinikum Würzburg, Medizinische Klinik und Poliklinik I, Oberdürrbacher Str. 6, 97080 Würzburg, Germany

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials